Design of an In Vitro Skin 3D Model Mimicking a Disruption of the Barrier Function

    September 2017 in “ Journal of Investigative Dermatology
    Pauline Rouaud, D. Boudier, Laetitia Marchand‐Martin, K. Servaes, Sylvie Bordes, B. Closs
    TLDR Activating the hexosamine pathway can improve skin health and increase hair follicle stem cells.
    This study developed a 3D in vitro model of Reconstructed Epidermis (RE) to mimic disrupted barrier function using normal human keratinocytes. The model was treated with 0.02% sodium lauryl sulfate (SLS) to induce stress, and transcriptomic analysis revealed 929 genes significantly modulated in stressed RE compared to control, with 473 down-regulated and 456 up-regulated. These changes mirrored those in subjects with disrupted barrier function, highlighting 6 over-represented pathways: inflammation, epidermis development, adhesion system, lipids metabolism, defense system, and transport system. The expression of 9 key biomarkers was validated, suggesting the model's potential as a tool for screening therapeutic molecules to repair barrier function.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 36 results

      community GHK Cu - is this the next best solution for hairloss?

      in Research/Science  19 upvotes 1 week ago
      GHK-Cu is discussed as a potential hair loss treatment, with claims of promoting hair growth and possibly reversing gray hair, though strong clinical evidence is limited. The user also mentions using Minoxidil, red light therapy, and microneedling.

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  52 upvotes 1 year ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

      community Best Treatment In The Pipeline?

      in Chat  15 upvotes 1 year ago
      New treatments for AGA are emerging, including pyrilutumide, gt0029, scube3, kx-826, and pp405. Verteporfin is mentioned as a promising option.

      community Has anyone else seen this encouraging verteporfin case study?

      in Progress Pictures  35 upvotes 2 years ago
      The conversation discusses the potential use of verteporfin for hair loss treatment, with one user mentioning their surgeon's interest in trying it and another noting its research status and clinical use as a YAP inhibitor. Some users debate the market size, availability of generics, and the optimism in the hair loss community regarding new treatments.

    Similar Research

    5 / 1000+ results